Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Aug 8;178:113918. doi: 10.1016/j.addr.2021.113918

Figure 4.

Figure 4.

Nanomedicine based approaches for delivering therapeutics to LC cells. (A) TEM images of PLGA - Chitosan nanoparticle (CSNP) for co-delivering RGD (arginine-glycine-aspartic acid) peptide and PTX to integrin αvβ3 receptors, (B) % drug loading and encapsulation efficiency of the nanocarrier and (C) in vitro drug release data from unmodified and modified nanocarrier. Image reproduced from Babu et al., 2017 [220] that is under an open access Creative Commons CC BY 4.0 licence.